Glory John
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.1% of the total across 898 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 898 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$3K
- UCB, Inc.$2K
- Modernatx, Inc.$2K
- Pfizer$1K
- Novartis$1K
- plus $5K from 17 others
What the payments were for
- Travel & lodging$1,2708%
- Food & beverage$15,06092%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 212 | $2,987 |
| AbbVie | 139 | $2,501 |
| UCB, Inc. | 117 | $1,912 |
| Modernatx, Inc. | 9 | $1,606 |
| Pfizer | 118 | $1,382 |
| Novartis | 55 | $1,085 |
| AstraZeneca(2 entities) | 36 | $815 |
| Lilly USA, LLC | 47 | $775 |
| Mallinckrodt Hospital Products Inc. | 25 | $701 |
| GSK | 33 | $524 |
| Johnson & Johnson | 31 | $509 |
| Radius Health, Inc. | 17 | $383 |
| E.r. Squibb & Sons, L.L.C. | 17 | $285 |
| Aurinia Pharma U.S., Inc. | 10 | $204 |
| Sandoz | 5 | $150 |
| Fresenius Kabi USA, LLC | 6 | $129 |
| Boehringer Ingelheim | 6 | $122 |
| Sanofi | 4 | $98 |
| Sobi, Inc | 5 | $92 |
| Organon | 3 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
How this compares
$16,357 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 23 | $3,359 |
| Tramadol Hcl | 44 | $127 |
Paid to pharmacies, not to this prescriber.
Other family in Ocoee
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.